Trial intelligence / Profile preview

Insulin Detemir vs NPH on Fat Distribution in T2D

NCT00795600Phase 4Completed

Sponsor
Novo Nordisk
Start
Apr 2009
Primary completion
Aug 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2009; status: completed.

02

Drugs

insulin detemir
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00795600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00795600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call